Description

Do you know a person with Autism Spectrum Disorder (ASD) who struggles with moodiness, irritability, tantrums or aggression?

Vanderbilt University is studying a new medication to help with these behaviors in children and teens with ASD. The purpose of this study is to find out if STX209 (R-Baclofen) is safe for people with ASD. We also want to know if it is helpful in treating the irritable behavior that goes along with ASD. In this study, STX209 will be compared to a placebo. All volunteers will have the medication at some point.

The study lasts 10 weeks. It involves 6 visits to Vanderbilt University in Nashville, TN. We need you to give blood at 3 of those visits.

There is no cost to you for being in this research study. You will get evaluations, study visits, and study medications at no cost. You will also get money back for your transportation costs and time.

Sponsored by Seaside Therapeutics.

Participant Criteria

• Children and teens with ASD
• ages 6-17
• who have trouble with moodiness, irritability, tantrums or aggression

Compensation

yes

Visit Requirements

6 visits to Vanderbilt University in Nashville, TN

Brochure

Download Brochure

Contact Information

Gina Murfree, RN
(615) 936-3288
Gina.Murfree@vanderbilt.edu